Synovus Financial Corp Has $3.84 Million Holdings in STERIS plc (NYSE:STE)

Synovus Financial Corp increased its holdings in shares of STERIS plc (NYSE:STE) by 1.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 18,698 shares of the medical equipment provider’s stock after acquiring an additional 344 shares during the period. Synovus Financial Corp’s holdings in STERIS were worth $3,844,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Avalon Trust Co acquired a new position in shares of STERIS during the 4th quarter worth about $30,000. Human Investing LLC acquired a new position in STERIS during the fourth quarter valued at approximately $31,000. Anfield Capital Management LLC grew its stake in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 91 shares in the last quarter. Central Pacific Bank Trust Division increased its position in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC increased its position in shares of STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 137 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on STE. JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a report on Thursday, April 10th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research note on Monday, April 7th. Stephens reaffirmed an “overweight” rating and issued a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. Finally, Piper Sandler lifted their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, STERIS has a consensus rating of “Moderate Buy” and an average price target of $258.75.

STERIS Trading Up 1.4 %

Shares of STE stock opened at $224.16 on Tuesday. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24. The firm has a 50 day moving average price of $222.67 and a two-hundred day moving average price of $219.40. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $22.02 billion, a PE ratio of 47.59 and a beta of 0.87.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, analysts predict that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.